摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-氯-1,3-二氢-3-甲基-5-(o-氯苯基)-2H-1,4-苯并二氮杂卓-2-硫酮 | 2894-71-5

中文名称
7-氯-1,3-二氢-3-甲基-5-(o-氯苯基)-2H-1,4-苯并二氮杂卓-2-硫酮
中文别名
——
英文名称
7-chloro-1,3-dihydro-5-(o-chlorophenyl)-2H-1,4-benzodiazepine-2-thione
英文别名
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-thione;1,3-dihydro-7-chloro-5-(2-chlorophenyl)-2H-1,4-benzodiazepine-2-thione;7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepine-2-thione
7-氯-1,3-二氢-3-甲基-5-(o-氯苯基)-2H-1,4-苯并二氮杂卓-2-硫酮化学式
CAS
2894-71-5
化学式
C15H10Cl2N2S
mdl
——
分子量
321.23
InChiKey
KFUPVMCNARYHKM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    251-253 °C
  • 沸点:
    437.8±55.0 °C(Predicted)
  • 密度:
    1.42±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    56.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:5ea72e242af15f85d015bcc275cf2a65
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Neurotropic and psychotropic agents. IV. Synthesis and pharmacological properties of 7-chloro-5-(2-chlorophenyl)-2-(2-dimethylaminoethylthio)-3H-1,4-benzodiazepine and related compounds.
    摘要:
    描述了7-氯-5-(2-氯苯基)-2-(2-二甲氨基乙基硫)-3H-1, 4-苯二氮卓(III-1)及相关化合物的合成和药理特性。化合物III-1是通过将硫内酰胺(II-1)与2-二甲氨基乙基氯在碱性水甲醇条件下反应而制备的,同时获得了副产物7-氯-5-(2-氯苯基)-2-甲氧基-3H-1, 4-苯二氮卓(IV)。后者(IV)在酸性介质中水解,生成甲基(E)-[2-氨基-5-氯-α-(2-氯苯基)苯乙烯]氨基乙酸酯(顺式)(XIX),该化合物经过进一步的酸处理转化为1, 4-苯二氮卓(I-1)。化合物XIX在加热时异构化为相应的反式(XXII)。大多数合成的化合物在小鼠中表现出类似于地西泮的抚慰和抗惊厥效果。
    DOI:
    10.1248/cpb.30.1141
  • 作为产物:
    描述:
    7-氯-5-(2-氯苯基)-1,3-二氢-3H-1,4-苯并二氮杂卓-2-酮tetraphosphorus decasulfide 作用下, 以 吡啶 为溶剂, 以65%的产率得到7-氯-1,3-二氢-3-甲基-5-(o-氯苯基)-2H-1,4-苯并二氮杂卓-2-硫酮
    参考文献:
    名称:
    S-Substituted derivatives of 8-chloro-6-(2-chlorophenyl)-1-mercaptomethyl-4H-s-triazolo[4,3-a]-1,4-benzodiazepine; Synthesis and pharmacology
    摘要:
    7-氯-5-苯基-1,3-二氢-1,4-苯并二氮杂硫杂环己烯-2-硫酮(XVIII)及其5-(2-氯苯基)类似物XIX与甲硫基、乙硫基、环己硫基、苯硫基、对甲苯硫基、对氯苯硫基、苄硫基、S-(2-二甲氨基乙基)硫基、2-呋喃基硫基和3-吡啶甲基硫基乙酸的肼在沸腾的丁醇中反应,得到物质VII和标题化合物VIII-XVII。描述了肼XXVIII-XXXII的合成。制备的化合物毒性很小,具有强烈的去协调活性,并且作为抗惊厥药物非常有效。在这方面,它们比阿普唑仑(II)活性更高,并且与三唑安定(III)相差无几。
    DOI:
    10.1135/cccc19830123
点击查看最新优质反应信息

文献信息

  • Potential hypnotics and anxiolytics in the 4H-s-triazolo[4,3-a]-1,4-benzodiazepine series: 8-Chloro-6-(2-chlorophenyl)-1-[4-(2-methoxyethyl)piperazino]-4H-s-triazolo[4,3-a]-1,4-benzodiazepine and some related compounds
    作者:Zdeněk Polívka、Miroslav Ryska、Jiří Holubek、Emil Svátek、Jan Metyš、Miroslav Protiva
    DOI:10.1135/cccc19832395
    日期:——

    1-Bromo derivatives XIIa and XIIb were prepared by bromination of 8-chloro-6-phenyl-4H-s-triazolo[4,3-a]-1,4-benzodiazepine (XIa) and its 6-(2-chlorophenyl) analogue XIb with bromine in chloroform in the presence of pyridine. Substitution reactions with 1-(2-methoxyethyl)piperazine (XIVb), 1-(3-methoxypropyl)piperazine (XVb), 1-(2-ethoxyethyl)piperazine (XVIb) and 1-(2-methylthioethyl)piperazine (XVIIb) afforded the title compound IIb and analogues IIa and IIIb-Vb. A substitution reaction of the bromo derivative XIIb with piperazine gave the 1-piperazino derivative VIIIb which was alkylated with 2-phenoxyethyl bromide and 2-phenylthioethyl bromide to give compounds VIb and VIIb. The title compound IIb has very high anticonvulsant and discoordinating activities in mice. The enlargement of the substituent R1 (compounds IIIb-VIIb) results in a gradual decrease of the effects mentioned.

    1-生物XIIa和XIIb是通过在氯仿中存在吡啶的情况下,用对8--6-苯基-4H-s-三唑并[4,3-a]-1,4-苯二氮杂环己烷(XIa)及其6-(2-氯苯基)类似物XIb进行化制备的。用1-(2-甲氧基乙基)哌嗪(XIVb)、1-(3-甲氧基丙基)哌嗪(XVb)、1-(2-乙氧基乙基)哌嗪(XVIb)和1-(2-甲硫基乙基)哌嗪(XVIIb)进行取代反应,得到了标题化合物IIb及其类似物IIa和IIIb-Vb。生物XIIb与哌嗪的取代反应得到了1-哌嗪基衍生物VIIIb,它与2-苯氧基乙和2-苯基乙烷基化,得到化合物VIb和VIIb。标题化合物IIb在小鼠中具有非常高的抗惊厥和失调活性。取代基R1的扩大(化合物IIIb-VIIb)导致上述效应逐渐减弱。
  • 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
    申请人:The Upjohn Company
    公开号:US03987052A1
    公开(公告)日:1976-10-19
    6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines of the formula (IV): ##SPC1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, phenyl, benzyl and -COOR' in which R' is alkyl of 1 to 4 carbon atoms, inclusive; wherein R.sub.1 is selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms, inclusive; and wherein R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, halogen, nitro, cyano, trifluoromethyl, and alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkanoylamino and dialkylamino in which the carbon chain moieties are of 1 to 3 carbon atoms, inclusive, are produced by condensing a 1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-thione of the formula (I): ##SPC2## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are defined as above, with an organic acid hydrazide of the formula: ##EQU1## wherein R is defined as above. The new products of formula IV including their pharmacologically acceptable acid addition salts are useful as sedatives, tranquilizers and muscle relaxants in mammals and birds.
    6-苯基-4H-s-三唑并[4,3-a][1,4]苯二氮杂环己烷化学式(IV):##SPC1##其中R选自由氢、1至3个碳原子的烷基、苯基、苄基和-COOR'的群,其中R'是1至4个碳原子的烷基;其中R.sub.1选自由氢和1至3个碳原子的烷基;其中R.sub.2、R.sub.3、R.sub.4和R.sub.5选自由氢、1至3个碳原子的烷基、卤素、硝基、基、三甲基和烷氧基、烷基、烷基亚基、烷基磺基、烷酰胺基和二烷基胺基,其中碳链基团为1至3个碳原子,通过将化学式(I)的1,3-二氢-5-苯基-2H-1,4-苯二氮杂环己烷-2-酮与化学式的有机酸酰缩合而制备:##SPC2##其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和R.sub.5如上所定义,与化学式的有机酸酰缩合:##EQU1##其中R如上所定义。公式IV的新产品及其药理学上可接受的酸盐在哺乳动物和鸟类中作为镇静剂、安定剂和肌肉松弛剂具有用途。
  • 2,4-Dihydro-6-phenyl-1H-s-triazolo[4,3-a][1,4]benzodiazepin-1-ones with antianxiety and antidepressant activity
    作者:Jackson B. Hester、Allan D. Rudzik、Philip Von Voigtlander
    DOI:10.1021/jm00178a010
    日期:1980.4
    4-dihydro-6-phenyl-1H-s-triazolo[4,3-a][1,4]benzodiazepin-1-ones was prepared and evaluated for central nervous system activity. It was found that the 2-methyl-substituted analogues had interesting activity in tests useful for detecting anxiolytic agents, while N-2 substitution with omega-(dialkylamino)alkyl substituents give compounds with antidepressant potential as well as antianxiety activity.
    制备了一系列的2,4-二氢-6-苯基-1H-s-三唑并[4,3-a] [1,4]苯并二氮杂-1-酮并评估了中枢神经系统的活性。发现2-甲基取代的类似物在用于检测抗焦虑剂的测试中具有令人感兴趣的活性,而用ω-(二烷基基)烷基取代基的N-2取代产生具有抗抑郁潜力以及抗焦虑活性的化合物。
  • 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
    申请人:The Upjohn Company
    公开号:US03933794A1
    公开(公告)日:1976-01-20
    Novel 6-substituted 4H-imidazo[1,2-a][1,4]benzodiazepines, the intermediate 5-substituted-2-(2-alkynylamino)-3H-1,4-benzodiazepines, pharmacologically acceptable acid addition salts thereof, and processes for their production. The compounds of this invention and the pharmacologically acceptable acid addition salts thereof are central nervous system depressants. They are useful as sedatives, hypnotics, tranquilizers, muscle relaxants and anticonvulsants, and also as feed additives for increasing growth rate and feed efficiency of livestock and poultry, milk production in the mammalian species and egg production in avian species.
    新型6-取代的4H-咪唑[1,2-a][1,4]苯二氮杂环己烷,中间体5-取代的2-(2-炔基基)-3H-1,4-苯二氮杂环己烷,其药理学上可接受的酸盐,以及它们的生产工艺。本发明的化合物及其药理学上可接受的酸盐是中枢神经系统抑制剂。它们可用作镇静剂、催眠药、镇定剂、肌肉松弛剂和抗惊厥剂,还可作为增加家畜和家禽生长速度和饲料效率、哺乳动物种类的产奶量和禽类种类的产蛋量的饲料添加剂。
  • Synthesis and spectral properties of 2-[(o- and p-substituted)aminophenyl] -3<i>H</i>-5-[(o- and<i>p</i>-substituted)phenyl]-7-chloro-1,4-benzodiazepines
    作者:Eduardo Cortés Cortés、Raúl Salazar Franco、Olivia García Mellado
    DOI:10.1002/jhet.5570380320
    日期:2001.5
    series of twelve new 2-[(o- and p-substituted)aminophenyl]-3H-5-[(o- and p-substituted)phenyl]-7-chloro-1,4-benzodiazepines, which have possible pharmacological properties has been obtained. The synthesis was carried out following six steps. The structure of all products was corroborated by ir, 1H nmr, 13C nmr and ms. In addition for the compound 2-(o-chloroaminophenyl)-3H-5-(o-fluorophenyl)-7-chloro-1
    一系列12新2 - [(ø -和p -取代的)基苯基] -3- ħ -5 - [(ø -和p -取代的)苯基] -7--1,4-苯并二氮杂类,其具有可能的药理学属性已获得。合成按照六个步骤进行。ir,1 H nmr,13 C nmr和ms证实了所有产物的结构。另外,对于化合物2-(邻基苯基)-3 H -5-(邻氟苯基)-7--1,4-苯并二氮杂pine7,通过X射线衍射确认了其结构。
查看更多